Outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) as an adjuvant therapy for rhino-orbital-cerebral mucormycosis (ROCM) following COVID-19

被引:4
|
作者
Shakrawal, Jyoti [1 ]
Sharma, Vidhu [2 ]
Goyal, Amit [2 ]
Kumar, Deepak [3 ]
Meena, Seema [1 ]
Tiwari, Sarbesh [4 ]
Jain, Vidhi [5 ]
Elhence, Poonam [6 ]
Soni, Kapil [2 ]
Choudhury, Bikram [2 ]
Bhatnagar, Kavita [1 ]
Garg, Mahendra Kumar [3 ]
Misra, Sanjeev [7 ]
机构
[1] All India Inst Med Sci AIIMS, Dept Ophthalmol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[2] All India Inst Med Sci AIIMS, Dept Otorhinolaryngol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[3] All India Inst Med Sci AIIMS, Dept Gen Med, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[4] All India Inst Med Sci AIIMS, Dept Diagnost & Intervent Radiol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[5] All India Inst Med Sci AIIMS, Dept Microbiol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[6] All India Inst Med Sci AIIMS, Dept Pathol & Lab Med, Basni Phase 2, Jodhpur 342005, Rajasthan, India
[7] All India Inst Med Sci AIIMS, Dept Surg Oncol, Basni Phase 2, Jodhpur 342005, Rajasthan, India
关键词
COVID-19; Transcutaneous retrobulbar Amphotericin B; Rhino-orbital-cerebral-mucormycosis; MANAGEMENT;
D O I
10.1007/s10792-022-02591-0
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To assess the outcomes of transcutaneous retrobulbar Amphotericin B (TRAMB) for rhino-orbital-cerebral-mucormycosis (ROCM) post-COVID-19, as an adjuvant to standard systemic antifungal therapy. Methods In this prospective cohort study involving ROCM patients with clinical/radiological orbital involvement, 44 eyes with ROCM stage >= 3B received TRAMB for 7 consecutive days with liposomal Amphotericin-B (3.5 mg/ml) with a minimum clinical and radiological follow-up of 3 months. All patients received standard systemic antifungal therapy also as per institutional protocol. Data pertaining to demography, systemic status, clinical involvement, imaging, surgical/medical management were also recorded. Potential eyes for exenteration were excluded. Please confirm if the author names are presented accurately and in the correct sequence (given name, middle name/initial, family name). Author 12 Given name: [Mahendra Kumar ] Last name [Garg]. Also, kindly confirm the details in the metadata are correct.All author names are presented accurately. Details in the metadata are correct. Thank you. Results Forty-four eyes of 42 patients were included, out of which 30 had diabetes mellitus & 22 had received steroid/oxygen treatment during COVID-19 infection. Forty eyes showed improvement or stable disease on follow-up on radiology. Four eyes which showed progression of the disease in orbit were reaugmented with TRAMB. No patient required exenteration. Subconjunctival haemorrhage occurred in six eyes and temporary blurring of vision in four eyes after TRAMB which resolved spontaneously. Conclusion TRAMB, as an adjuvant to standard systemic antifungal therapy, is associated with a significant reduction or stabilisation of orbital involvement. TRAMB should be considered as an adjuvant therapy for ROCM to reduce disease progression as well as to preserve globe or sight. It has a promising role in preventing potential orbital exenterations.
引用
收藏
页码:1919 / 1926
页数:8
相关论文
共 50 条
  • [31] Retrobulbar Injection of Amphotericin B in Patients With COVID-19 Associated Orbital Mucormycosis: A Systematic Review
    Sharifi, Ali
    Akbari, Zahra
    Shafie'ei, Mohammad
    Nasiri, Naser
    Sharifi, Meraj
    Shafiei, Mohadeseh
    Zand, Amin
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2022, 38 (05) : 425 - 432
  • [32] Retrobulbar Amphotericin B Injection in Curbing the Progression of COVID Associated Rhino-orbital Cerebral Mucormycosis: A Retrospective Case Series
    Madhumallika Pathak
    Vijaya Sahu
    Ripu Daman Arora
    Martina M. Shambharkar
    Prithvi Naveen
    Saroj Kumar Pati
    Nitin M. Nagarkar
    Indian Journal of Otolaryngology and Head & Neck Surgery, 2022, 74 : 3352 - 3358
  • [33] COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran
    Mahsa Abdorahimi
    Farzad Pakdel
    Mohammadreza Salehi
    Laura Alcazar-Fuoli
    Seyed Jamal Hashemi
    Roshanak Daie Ghazvini
    Fardin Ahmadkhani
    Kazem Ahmadikia
    Alireza Abdollahi
    Juan Carlos Soto Debran
    Azin Tabari
    Fatemeh Farrokh
    Atefeh Mousavand
    Pegah Afarinesh Khaki
    Arezoo Salami Khaneshan
    Ashraf S. Ibrahim
    Sadegh Khodavaisy
    Mycopathologia, 2023, 188 : 783 - 792
  • [34] A Retrospective Study of Imaging of Invasive Rhino-Orbital-Cerebral Mucormycosis in the COVID-19 Pandemic in a Tertiary Care Center
    Ranjan, Pushpa
    Kumar, Vinod
    Sinha, Neetu
    Jaiswal, Aditya Abhishek
    Kumar, Deepak
    Suman, Sanjay K.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [35] COVID-19 Associated Rhino-Orbital-Cerebral Mucormycosis: Clinical Features, Antifungal Susceptibility, Management and Outcome in a Tertiary Hospital in Iran
    Abdorahimi, Mahsa
    Pakdel, Farzad
    Salehi, Mohammadreza
    Alcazar-Fuoli, Laura
    Hashemi, Seyed Jamal
    Daie Ghazvini, Roshanak
    Ahmadkhani, Fardin
    Ahmadikia, Kazem
    Abdollahi, Alireza
    Debran, Juan Carlos Soto
    Tabari, Azin
    Farrokh, Fatemeh
    Mousavand, Atefeh
    Khaki, Pegah Afarinesh
    Khaneshan, Arezoo Salami
    Ibrahim, Ashraf S.
    Khodavaisy, Sadegh
    MYCOPATHOLOGIA, 2023, 188 (05) : 783 - 792
  • [36] COVID-19 associated rhino-orbital-cerebral mucormycosis: An observational study from Eastern India, with special emphasis on neurological spectrum
    Dubey, Souvik
    Mukherjee, Debaleena
    Sarkar, Peyalee
    Mukhopadhyay, Pradip
    Barman, Debasis
    Bandopadhyay, Manimoy
    Pandit, Alak
    Sengupta, Amitabha
    Das, Sudip
    Ghosh, Soumitra
    Adhikari, Souvik
    Biswas, Partha Sundar
    Pal, Pranabananda
    Roy, Himadri
    Patra, Nilanjana
    Das, Amrita
    Sinha, Pallab
    Mondal, Md. Karimulla
    Shrivastava, Smiti Rani
    Bhattacharya, Kumkum
    Mukhopadhyay, Madhumita
    Ahmed, Kamraan
    Halder, Tushar Kanti
    Saha, Mainak
    Ahmed, Kaoshar
    Maity, Souvik
    Mandal, Abhishek
    Chatterjee, Deblina
    Saha, Srijana
    Chunakar, Arpita
    Saha, Alangkar
    Ray, Biman Kanti
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2021, 15 (05)
  • [37] Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review
    Bhattacharyya, Anusuya
    Sarma, Phulen
    Sharma, Dibya Jyoti
    Das, Karuna Kumar
    Kaur, Hardeep
    Prajapat, Manisha
    Kumar, Subodh
    Bansal, Seema
    Prakash, Ajay
    Avti, Pramod
    Thota, Prasad
    Reddy, Dibbanti Harikrishna
    Gautam, Bhaswati Sharma
    Medhi, Bikash
    INDIAN JOURNAL OF PHARMACOLOGY, 2021, 53 (04) : 317 - 327
  • [38] Imaging of COVID-19-associated rhino-orbital-cerebral mucormycosis: imaging analysis of 120 patients
    Alka Agrawal
    Yogita Dixit
    Vivek Yonati
    Prakhar Nigam
    Pramita Kheti
    The Egyptian Journal of Otolaryngology, 2022, 38
  • [39] Imaging of COVID-19-associated rhino-orbital-cerebral mucormycosis: imaging analysis of 120 patients
    Agrawal, Alka
    Dixit, Yogita
    Yonati, Vivek
    Nigam, Prakhar
    Kheti, Pramita
    EGYPTIAN JOURNAL OF OTOLARYNGOLOGY, 2022, 38 (01)
  • [40] Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India
    Yadav, Himanshu
    Sen, Snigdha
    Nath, Tirupati
    Mazumdar, Shefali
    Jain, Anu
    Verma, Pinky
    Gupta, Preeti
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2022, 70 (06) : 2163 - 2168